Natural history of children with mild Crohn’s disease

Abstract

BACKGROUND There is a small and poorly studied population of patients with mild and limited Crohn’s disease (CD), who either spontaneously enter remission and can discontinue therapy, or be maintained on milder anti-inflammatory treatment. AIM To identify a group of children with mild CD who were not escalated to immunomodulators (azathioprine, mercaptopurine, or methotrexate) or biologics (infliximab or adalimumab) within the first two years after their Crohn’s diagnosis and outline the natural history and phenotypic features of these patients. METHODS In a retrospective chart review of the inflammatory bowel disease database at Boston Children’s Hospital we reviewed all the mild CD patient’s clinic visits, laboratory studies, and procedures for the duration of time they were followed at the center. Patients were included if they had clear diagnosis of Crohn’s disease, and they were not escalated to immunosuppressive therapies for at least 2 years after the date of diagnosis. These mild CD patients were compared to controls diagnosed at a similar time, that were treated with immunomodulators or biologics. Data that was abstracted included: Age at diagnosis, sex, disease location utilizing the Paris classification, medical treatment, surgical treatment, endoscopic findings, histology, and hospitalizations. We also analyzed differences in the phenotypic features between those with mild CD and those with moderate to severe disease. RESULTS Out of 1205 patients with CD diagnosed between 1990 and 2013, we identified 29 patients that met the inclusion criteria, and they were matched with 58 controls. There were no significant differences between the disease behaviors at presentation, with approximately 90% of patients in each group having inflammatory disease. However, patients with mild disease were more likely to have disease limited to the colon (31% vs 12%, P = 0.03). In contrast, patients with moderate to severe disease (aka control group) were more likely to have ileocolonic disease (70% vs 45% in the mild group, P = 0.02). Of the 29 patients, only 8 required medication escalation to immunomodulators during the period of follow-up. The primary indication for escalation to immune suppressive therapies was corticosteroid dependence. We also found that patients treated without immunomodulators or biologics for mild CD continue to exhibit histologic intestinal inflammation. Of the 29 patients, three developed significant complications of ileal disease, though only one required surgical intervention during the period of follow-up. CONCLUSION We identified a cohort of children with mild CD, who were able to avoid the institution of immune suppressive therapies for several years, and generally had good outcomes during the period of follow-up. While a subset of these patients will ev...

Methotrexate for Primary Maintenance Therapy in Mild-to-Moderate Crohn Disease in Children

“…However, this leaves pediatric gastroenterologists with the common conundrum of how to treat the patient with mild-to-moderate CD. The lack of established efficacy of 5ASA in CD makes these an unattractive option (14); a recent study of those patients with mild CD did demonstrate overall improvement, but not resolution of inflammation, on 5ASA (15). Anti-TNFs have the disadvantage of route of administration as well as cost of therapy.…”

Early Indolent Course of Crohn’s Disease in Newly Diagnosed Patients Is Not Rare and Possibly Predictable

“…[4][5][6][7] Nonetheless, about 25% of patients present with mild CD and will have a prolonged indolent course of disease. [8][9][10] Accordingly, the European Crohn's and Colitis guidelines recommend only a short course of budesonide, or even a watchful-waiting approach for these patients. 7 Serologic responses to microbial antigens and some genetic variations were associated with disease progression, 11,12 and there are integrative tools that combine clinical and biological factors at diagnosis to predict the risk for complications.…”

Severe, Recurrent Anemia in a 17-Year-Old Female

“…Last, both spontaneous remission 19 and avoidance of immunosuppressive therapy 20 for patients with mild CD are well-cited in the literature and well-exemplified in this patient's presentation.…”